Semler Scientific Trades Well Below Strive Takeout Value Amid Bitcoin Treasury M&A Wave

Shares of Semler Scientific (SMLR) closed at $32.06 yesterday, significantly below the implied $86.30 takeout price in its all-stock acquisition by Strive (ASST). Benchmark analyst Mark Palmer described the unusually wide arbitrage spread as both a reflection of market skepticism and a potential opportunity in the emerging wave of bitcoin treasury mergers.

Palmer reaffirmed his buy rating on Semler while adjusting the stock’s price target to $86 from $101, reflecting the terms of the Strive deal. The fixed exchange ratio of 21.05 Strive shares per Semler share suggests a potentially lucrative arbitrage play for investors, particularly with both boards having approved the transaction.

The merger would consolidate Strive’s 5,886 BTC with Semler’s 5,021 BTC, creating a combined reserve of 10,907 bitcoins — enough to rank 12th among publicly traded companies by crypto holdings, trailing only Strategy, according to Benchmark.

Beyond crypto reserves, the deal gives Strive access to Semler’s diagnostics business, which the company plans to monetize or spin off post-closing. This cash-flowing asset provides additional flexibility compared with pure bitcoin treasury plays, Palmer noted.

Benchmark views the transaction as the first major move in what could become a broader trend of stock-for-stock mergers in the bitcoin treasury sector. By leveraging equity rather than debt, Strive aims to acquire BTC at favorable prices while avoiding maturity and margin risks associated with traditional financing.

However, risks remain. The transaction requires an effective S-4 registration and Semler shareholder approval. Any significant drop in Strive’s stock or the bitcoin price ahead of the vote could pressure the deal terms. “If Strive’s share price weakens materially into the vote, the implied value to SMLR drops, possibly inviting renegotiation pressure or widening the arbitrage haircut,” Benchmark cautioned.

Premarket, SMLR shares were up 2.5% to $32.86, while ASST slipped 4.9% to $3.90.